A detailed history of Creative Planning transactions in Alector, Inc. stock. As of the latest transaction made, Creative Planning holds 19,117 shares of ALEC stock, worth $49,130. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,117
Previous 12,394 54.24%
Holding current value
$49,130
Previous $56,000 58.93%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$4.34 - $6.58 $29,177 - $44,237
6,723 Added 54.24%
19,117 $89,000
Q2 2024

Aug 15, 2024

BUY
$4.19 - $6.23 $51,930 - $77,214
12,394 New
12,394 $56,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $212M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.